ADBiotech Co., Ltd.

A179530

KR7179530001

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
2,620 ^KRW	-0.38%		-0.19%	-20.00%

Apr. 26	ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd	CI
Apr. 25	ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd	CI

ADBiotech Co., Ltd. announced that it has received KRW 1 billion in funding

July 08, 2020

On July 9, 2020, ADBiotech Co., Ltd. (XKON:A179530) closed the transaction.

Latest news about ADBiotech Co., Ltd.

ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd	Apr. 25	CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding from Kiwoom Securities Co., Ltd., NH Investment & Securities Co., Ltd., Samsung Securities Co.,Ltd., Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd	Apr. 24	CI
ADBiotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-22	CI
ADBiotech Co., Ltd. agreed to acquire a 19.36% stake in Wiju Inc. for KRW 1.29 billion.	23-01-15	CI
ADBiotech Co., Ltd. announced that it has received KRW 4.5 billion in funding	21-05-02	CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding	21-04-21	CI
ADBiotech Co., Ltd. announced that it has received KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.	20-07-08	CI
ADBiotech Co., Ltd. announced that it has received KRW 1 billion in funding	20-07-08	CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 1 billion in funding	20-06-29	CI
ADBiotech Co., Ltd. announced that it expects to receive KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.	20-06-28	CI
Quest PharmaTech, Inc. announced that it has received CAD 1 million in funding from AD Biotech. Co., Ltd and another investor.	14-01-28	CI
Quest PharmaTech, Inc. announced that it expects to receive CAD 1 million in funding.	13-11-20	CI

ADBiotech Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of veterinary drugs. The Company operates its business through two segments. Veterinary Medicine segment is engaged in the manufacture and sale of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, synthetic antibacterial agents and others. The Supplementary Feed segment is engaged in the manufacture and sale of functional supplementary feeds and other products.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Veterinary Drugs

	1st Jan change	Capi.
ADBIOTECH CO., LTD.	-20.00%	17.7M
ZOETIS INC.	-11.83%	79.42B
BLUESTAR ADISSEO COMPANY	+28.00%	3.8B
VIRBAC	-1.39%	3.23B
VIMIAN GROUP AB	+21.28%	1.75B
JINYU BIO-TECHNOLOGY CO., LTD.	-3.25%	1.61B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-18.63%	1.36B
VETOQUINOL SA	-1.17%	1.3B
WUHAN KEQIAN BIOLOGY CO.,LTD	-6.77%	1.22B
PULIKE BIOLOGICAL ENGINEERING, INC.	+2.34%	1.11B

Veterinary Drugs

ADBiotech Co., Ltd.

Equities

A179530

KR7179530001

Pharmaceuticals

ADBiotech Co., Ltd. announced that it has received KRW 1 billion in funding

Latest news about ADBiotech Co., Ltd.

Chart ADBiotech Co., Ltd.

Company Profile

Income Statement Evolution

Sector Veterinary Drugs